ASBPWNCM
Aspire Biopharma Holdings, Inc.
-1.0% · 90d
$0.02
+0.00 (+31.13%)
News
(2)April 2026
2 weeks agoS-1/A
Aspire Biopharma Holdings, Inc. — S-1/A Filing
ASBPWAspire Biopharma Holdings, Inc.
# 🧾 What This Document Is This is an **amended registration statement (S-1/A)**. Think of it as the final paperwork needed to let certain investors sell the shares they recently bought from the company. * **Why it exists:** Aspire Biopharma raised $11 million in February 2026 by selling special
Read summaryView on SEC EDGAR
March 2026
0 months ago10-K
Aspire Biopharma Holdings, Inc. — 10-K Filing
ASBPWAspire Biopharma Holdings, Inc.
# 🧾 What This Document Is This is Aspire Biopharma's **10-K annual report**, the comprehensive yearly filing required by the SEC for public companies. It’s a deep dive into their business operations, financial performance, and the risks they face. Think of it as the company's official report card f
Read summaryView on SEC EDGAR